New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2013
07:04 EDTTHRXFDA panel vote on olodaterol positive for Theravance drug, says Piper Jaffray
Piper Jaffray believes the positive FDA panel recommendation for Boehringer's olodaterol in COPD signals a similar outcome for Theravance's Breo's panel on March 7. The firm recommends buying shares of Theravance ahead of the FDA panel and keeps an Overweight rating on the name with a $32 price target.
News For THRX From The Last 14 Days
Check below for free stories on THRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for THRX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use